nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.179	0.302	CbGbCtD
Ezogabine—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.143	0.24	CbGbCtD
Ezogabine—UGT1A3—Losartan—type 2 diabetes mellitus	0.116	0.194	CbGbCtD
Ezogabine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0847	0.142	CbGbCtD
Ezogabine—UGT1A1—Losartan—type 2 diabetes mellitus	0.0723	0.121	CbGbCtD
Ezogabine—Flupirtine—ADRA2A—type 2 diabetes mellitus	0.00638	1	CrCbGaD
Ezogabine—KCNQ4—retina—type 2 diabetes mellitus	0.00149	0.153	CbGeAlD
Ezogabine—KCNQ5—retina—type 2 diabetes mellitus	0.00145	0.149	CbGeAlD
Ezogabine—KCNQ3—cardiovascular system—type 2 diabetes mellitus	0.000986	0.101	CbGeAlD
Ezogabine—UGT1A4—kidney—type 2 diabetes mellitus	0.000911	0.0933	CbGeAlD
Ezogabine—NAT2—liver—type 2 diabetes mellitus	0.000894	0.0915	CbGeAlD
Ezogabine—UGT1A9—kidney—type 2 diabetes mellitus	0.000764	0.0782	CbGeAlD
Ezogabine—UGT1A3—liver—type 2 diabetes mellitus	0.000677	0.0693	CbGeAlD
Ezogabine—UGT1A4—liver—type 2 diabetes mellitus	0.000576	0.059	CbGeAlD
Ezogabine—UGT1A1—kidney—type 2 diabetes mellitus	0.000523	0.0536	CbGeAlD
Ezogabine—UGT1A9—liver—type 2 diabetes mellitus	0.000483	0.0494	CbGeAlD
Ezogabine—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000398	0.0407	CbGeAlD
Ezogabine—UGT1A1—liver—type 2 diabetes mellitus	0.000331	0.0339	CbGeAlD
Ezogabine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000325	0.00148	CcSEcCtD
Ezogabine—Malaise—Gliclazide—type 2 diabetes mellitus	0.000324	0.00147	CcSEcCtD
Ezogabine—Rash—Repaglinide—type 2 diabetes mellitus	0.000323	0.00147	CcSEcCtD
Ezogabine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000323	0.00147	CcSEcCtD
Ezogabine—Eye disorder—Metformin—type 2 diabetes mellitus	0.000322	0.00147	CcSEcCtD
Ezogabine—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000322	0.00146	CcSEcCtD
Ezogabine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000321	0.00146	CcSEcCtD
Ezogabine—Shock—Glyburide—type 2 diabetes mellitus	0.000321	0.00146	CcSEcCtD
Ezogabine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000321	0.00146	CcSEcCtD
Ezogabine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00032	0.00146	CcSEcCtD
Ezogabine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00032	0.00146	CcSEcCtD
Ezogabine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00032	0.00146	CcSEcCtD
Ezogabine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000319	0.00145	CcSEcCtD
Ezogabine—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000319	0.00145	CcSEcCtD
Ezogabine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000318	0.00145	CcSEcCtD
Ezogabine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000317	0.00144	CcSEcCtD
Ezogabine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000317	0.00144	CcSEcCtD
Ezogabine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000316	0.00143	CcSEcCtD
Ezogabine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000315	0.00143	CcSEcCtD
Ezogabine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00143	CcSEcCtD
Ezogabine—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000314	0.00143	CcSEcCtD
Ezogabine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000313	0.00142	CcSEcCtD
Ezogabine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000311	0.00141	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000308	0.0014	CcSEcCtD
Ezogabine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000308	0.0014	CcSEcCtD
Ezogabine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000307	0.0014	CcSEcCtD
Ezogabine—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000307	0.0014	CcSEcCtD
Ezogabine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000305	0.00139	CcSEcCtD
Ezogabine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000305	0.00139	CcSEcCtD
Ezogabine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000305	0.00139	CcSEcCtD
Ezogabine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000305	0.00139	CcSEcCtD
Ezogabine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000304	0.00138	CcSEcCtD
Ezogabine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000304	0.00138	CcSEcCtD
Ezogabine—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000302	0.00138	CcSEcCtD
Ezogabine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000302	0.00137	CcSEcCtD
Ezogabine—Malnutrition—Metformin—type 2 diabetes mellitus	0.0003	0.00137	CcSEcCtD
Ezogabine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000299	0.00136	CcSEcCtD
Ezogabine—Weight increased—Ramipril—type 2 diabetes mellitus	0.000299	0.00136	CcSEcCtD
Ezogabine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000296	0.00135	CcSEcCtD
Ezogabine—Syncope—Valsartan—type 2 diabetes mellitus	0.000296	0.00135	CcSEcCtD
Ezogabine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000295	0.00134	CcSEcCtD
Ezogabine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000294	0.00134	CcSEcCtD
Ezogabine—Malaise—Orlistat—type 2 diabetes mellitus	0.000294	0.00134	CcSEcCtD
Ezogabine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000293	0.00133	CcSEcCtD
Ezogabine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000293	0.00133	CcSEcCtD
Ezogabine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000291	0.00133	CcSEcCtD
Ezogabine—Infection—Gliclazide—type 2 diabetes mellitus	0.000291	0.00132	CcSEcCtD
Ezogabine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000291	0.00132	CcSEcCtD
Ezogabine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00029	0.00132	CcSEcCtD
Ezogabine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000289	0.00131	CcSEcCtD
Ezogabine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000288	0.00131	CcSEcCtD
Ezogabine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000287	0.00131	CcSEcCtD
Ezogabine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000287	0.00131	CcSEcCtD
Ezogabine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000287	0.0013	CcSEcCtD
Ezogabine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000284	0.00129	CcSEcCtD
Ezogabine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000283	0.00129	CcSEcCtD
Ezogabine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000283	0.00129	CcSEcCtD
Ezogabine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000283	0.00129	CcSEcCtD
Ezogabine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000283	0.00129	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000282	0.00128	CcSEcCtD
Ezogabine—Tremor—Metformin—type 2 diabetes mellitus	0.000281	0.00128	CcSEcCtD
Ezogabine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00028	0.00127	CcSEcCtD
Ezogabine—Anxiety—Valsartan—type 2 diabetes mellitus	0.00028	0.00127	CcSEcCtD
Ezogabine—CYP2A6—liver—type 2 diabetes mellitus	0.000279	0.0285	CbGeAlD
Ezogabine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000279	0.00127	CcSEcCtD
Ezogabine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000277	0.00126	CcSEcCtD
Ezogabine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000276	0.00126	CcSEcCtD
Ezogabine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000275	0.00125	CcSEcCtD
Ezogabine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000274	0.00125	CcSEcCtD
Ezogabine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000272	0.00124	CcSEcCtD
Ezogabine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000271	0.00123	CcSEcCtD
Ezogabine—Malaise—Metformin—type 2 diabetes mellitus	0.000271	0.00123	CcSEcCtD
Ezogabine—Alopecia—Losartan—type 2 diabetes mellitus	0.000271	0.00123	CcSEcCtD
Ezogabine—Syncope—Metformin—type 2 diabetes mellitus	0.000269	0.00122	CcSEcCtD
Ezogabine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000269	0.00122	CcSEcCtD
Ezogabine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000269	0.00122	CcSEcCtD
Ezogabine—Infection—Valsartan—type 2 diabetes mellitus	0.000267	0.00122	CcSEcCtD
Ezogabine—Rash—Glipizide—type 2 diabetes mellitus	0.000267	0.00122	CcSEcCtD
Ezogabine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000267	0.00121	CcSEcCtD
Ezogabine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000267	0.00121	CcSEcCtD
Ezogabine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000266	0.00121	CcSEcCtD
Ezogabine—Shock—Valsartan—type 2 diabetes mellitus	0.000265	0.0012	CcSEcCtD
Ezogabine—Infection—Orlistat—type 2 diabetes mellitus	0.000264	0.0012	CcSEcCtD
Ezogabine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000264	0.0012	CcSEcCtD
Ezogabine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000264	0.0012	CcSEcCtD
Ezogabine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000264	0.0012	CcSEcCtD
Ezogabine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000263	0.0012	CcSEcCtD
Ezogabine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000263	0.0012	CcSEcCtD
Ezogabine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000262	0.00119	CcSEcCtD
Ezogabine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000261	0.00119	CcSEcCtD
Ezogabine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000261	0.00119	CcSEcCtD
Ezogabine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000261	0.00119	CcSEcCtD
Ezogabine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00026	0.00118	CcSEcCtD
Ezogabine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000259	0.00118	CcSEcCtD
Ezogabine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000258	0.00117	CcSEcCtD
Ezogabine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000257	0.00117	CcSEcCtD
Ezogabine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000256	0.00117	CcSEcCtD
Ezogabine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00116	CcSEcCtD
Ezogabine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000256	0.00116	CcSEcCtD
Ezogabine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000255	0.00116	CcSEcCtD
Ezogabine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000254	0.00116	CcSEcCtD
Ezogabine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000254	0.00115	CcSEcCtD
Ezogabine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000253	0.00115	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000253	0.00115	CcSEcCtD
Ezogabine—Discomfort—Metformin—type 2 diabetes mellitus	0.000253	0.00115	CcSEcCtD
Ezogabine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000253	0.00115	CcSEcCtD
Ezogabine—Nausea—Glipizide—type 2 diabetes mellitus	0.000252	0.00115	CcSEcCtD
Ezogabine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000251	0.00114	CcSEcCtD
Ezogabine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000251	0.00114	CcSEcCtD
Ezogabine—Tremor—Losartan—type 2 diabetes mellitus	0.00025	0.00114	CcSEcCtD
Ezogabine—Rash—Glimepiride—type 2 diabetes mellitus	0.000249	0.00113	CcSEcCtD
Ezogabine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000249	0.00113	CcSEcCtD
Ezogabine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000249	0.00113	CcSEcCtD
Ezogabine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000249	0.00113	CcSEcCtD
Ezogabine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00113	CcSEcCtD
Ezogabine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000247	0.00113	CcSEcCtD
Ezogabine—Infection—Metformin—type 2 diabetes mellitus	0.000244	0.00111	CcSEcCtD
Ezogabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000242	0.0011	CcSEcCtD
Ezogabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000241	0.0011	CcSEcCtD
Ezogabine—Shock—Metformin—type 2 diabetes mellitus	0.000241	0.0011	CcSEcCtD
Ezogabine—Malaise—Losartan—type 2 diabetes mellitus	0.000241	0.00109	CcSEcCtD
Ezogabine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00024	0.00109	CcSEcCtD
Ezogabine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00024	0.00109	CcSEcCtD
Ezogabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00024	0.00109	CcSEcCtD
Ezogabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00024	0.00109	CcSEcCtD
Ezogabine—Vertigo—Losartan—type 2 diabetes mellitus	0.00024	0.00109	CcSEcCtD
Ezogabine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000239	0.00109	CcSEcCtD
Ezogabine—Syncope—Losartan—type 2 diabetes mellitus	0.000239	0.00109	CcSEcCtD
Ezogabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000239	0.00109	CcSEcCtD
Ezogabine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000239	0.00109	CcSEcCtD
Ezogabine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000238	0.00108	CcSEcCtD
Ezogabine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000237	0.00108	CcSEcCtD
Ezogabine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000237	0.00108	CcSEcCtD
Ezogabine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000236	0.00107	CcSEcCtD
Ezogabine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000236	0.00107	CcSEcCtD
Ezogabine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000235	0.00107	CcSEcCtD
Ezogabine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000234	0.00107	CcSEcCtD
Ezogabine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000234	0.00107	CcSEcCtD
Ezogabine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000234	0.00106	CcSEcCtD
Ezogabine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000234	0.00106	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000232	0.00106	CcSEcCtD
Ezogabine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000232	0.00106	CcSEcCtD
Ezogabine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000232	0.00106	CcSEcCtD
Ezogabine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00023	0.00105	CcSEcCtD
Ezogabine—Constipation—Valsartan—type 2 diabetes mellitus	0.00023	0.00105	CcSEcCtD
Ezogabine—Infection—Irbesartan—type 2 diabetes mellitus	0.00023	0.00105	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00023	0.00104	CcSEcCtD
Ezogabine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000229	0.00104	CcSEcCtD
Ezogabine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000229	0.00104	CcSEcCtD
Ezogabine—Shock—Irbesartan—type 2 diabetes mellitus	0.000228	0.00103	CcSEcCtD
Ezogabine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000227	0.00103	CcSEcCtD
Ezogabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000226	0.00103	CcSEcCtD
Ezogabine—Anxiety—Losartan—type 2 diabetes mellitus	0.000226	0.00103	CcSEcCtD
Ezogabine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00102	CcSEcCtD
Ezogabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00102	CcSEcCtD
Ezogabine—Discomfort—Losartan—type 2 diabetes mellitus	0.000224	0.00102	CcSEcCtD
Ezogabine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000224	0.00102	CcSEcCtD
Ezogabine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000222	0.00101	CcSEcCtD
Ezogabine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00022	0.001	CcSEcCtD
Ezogabine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00022	0.001	CcSEcCtD
Ezogabine—Confusional state—Losartan—type 2 diabetes mellitus	0.000219	0.000998	CcSEcCtD
Ezogabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000219	0.000997	CcSEcCtD
Ezogabine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000219	0.000994	CcSEcCtD
Ezogabine—Somnolence—Metformin—type 2 diabetes mellitus	0.000218	0.000991	CcSEcCtD
Ezogabine—Infection—Losartan—type 2 diabetes mellitus	0.000216	0.000984	CcSEcCtD
Ezogabine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000216	0.000981	CcSEcCtD
Ezogabine—Tremor—Ramipril—type 2 diabetes mellitus	0.000214	0.000975	CcSEcCtD
Ezogabine—Shock—Losartan—type 2 diabetes mellitus	0.000214	0.000974	CcSEcCtD
Ezogabine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000213	0.000971	CcSEcCtD
Ezogabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000213	0.000969	CcSEcCtD
Ezogabine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000212	0.000965	CcSEcCtD
Ezogabine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000212	0.000964	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000212	0.000962	CcSEcCtD
Ezogabine—Fatigue—Metformin—type 2 diabetes mellitus	0.000211	0.000961	CcSEcCtD
Ezogabine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00021	0.000957	CcSEcCtD
Ezogabine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00021	0.000956	CcSEcCtD
Ezogabine—Constipation—Metformin—type 2 diabetes mellitus	0.00021	0.000953	CcSEcCtD
Ezogabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000208	0.000945	CcSEcCtD
Ezogabine—Malaise—Ramipril—type 2 diabetes mellitus	0.000206	0.000938	CcSEcCtD
Ezogabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000206	0.000938	CcSEcCtD
Ezogabine—Rash—Glyburide—type 2 diabetes mellitus	0.000206	0.000936	CcSEcCtD
Ezogabine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000206	0.000935	CcSEcCtD
Ezogabine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000206	0.000935	CcSEcCtD
Ezogabine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000205	0.000935	CcSEcCtD
Ezogabine—Syncope—Ramipril—type 2 diabetes mellitus	0.000205	0.000933	CcSEcCtD
Ezogabine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000205	0.000931	CcSEcCtD
Ezogabine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000204	0.000926	CcSEcCtD
Ezogabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000202	0.000919	CcSEcCtD
Ezogabine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000201	0.000914	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.0002	0.000908	CcSEcCtD
Ezogabine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000199	0.000907	CcSEcCtD
Ezogabine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000198	0.0009	CcSEcCtD
Ezogabine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000195	0.000889	CcSEcCtD
Ezogabine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000194	0.000883	CcSEcCtD
Ezogabine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000194	0.000882	CcSEcCtD
Ezogabine—Nausea—Glyburide—type 2 diabetes mellitus	0.000194	0.000881	CcSEcCtD
Ezogabine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000194	0.000881	CcSEcCtD
Ezogabine—Somnolence—Losartan—type 2 diabetes mellitus	0.000194	0.00088	CcSEcCtD
Ezogabine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000193	0.000878	CcSEcCtD
Ezogabine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000192	0.000875	CcSEcCtD
Ezogabine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000192	0.000871	CcSEcCtD
Ezogabine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000191	0.000868	CcSEcCtD
Ezogabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000191	0.000867	CcSEcCtD
Ezogabine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00019	0.000866	CcSEcCtD
Ezogabine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000188	0.000856	CcSEcCtD
Ezogabine—Fatigue—Losartan—type 2 diabetes mellitus	0.000188	0.000854	CcSEcCtD
Ezogabine—Constipation—Losartan—type 2 diabetes mellitus	0.000186	0.000847	CcSEcCtD
Ezogabine—Rash—Gliclazide—type 2 diabetes mellitus	0.000185	0.00084	CcSEcCtD
Ezogabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000185	0.000839	CcSEcCtD
Ezogabine—Shock—Ramipril—type 2 diabetes mellitus	0.000184	0.000835	CcSEcCtD
Ezogabine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000183	0.000832	CcSEcCtD
Ezogabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000183	0.000831	CcSEcCtD
Ezogabine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00018	0.000821	CcSEcCtD
Ezogabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000179	0.000816	CcSEcCtD
Ezogabine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000178	0.000809	CcSEcCtD
Ezogabine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000176	0.0008	CcSEcCtD
Ezogabine—Asthenia—Metformin—type 2 diabetes mellitus	0.000176	0.0008	CcSEcCtD
Ezogabine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000174	0.000791	CcSEcCtD
Ezogabine—Rash—Valsartan—type 2 diabetes mellitus	0.00017	0.000772	CcSEcCtD
Ezogabine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00017	0.000771	CcSEcCtD
Ezogabine—Rash—Orlistat—type 2 diabetes mellitus	0.000168	0.000763	CcSEcCtD
Ezogabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000168	0.000762	CcSEcCtD
Ezogabine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000168	0.000762	CcSEcCtD
Ezogabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000166	0.000757	CcSEcCtD
Ezogabine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000166	0.000755	CcSEcCtD
Ezogabine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000166	0.000755	CcSEcCtD
Ezogabine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000164	0.000747	CcSEcCtD
Ezogabine—Dizziness—Metformin—type 2 diabetes mellitus	0.000162	0.000737	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000161	0.000733	CcSEcCtD
Ezogabine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000161	0.000732	CcSEcCtD
Ezogabine—Nausea—Valsartan—type 2 diabetes mellitus	0.00016	0.000727	CcSEcCtD
Ezogabine—Constipation—Ramipril—type 2 diabetes mellitus	0.00016	0.000726	CcSEcCtD
Ezogabine—Nausea—Orlistat—type 2 diabetes mellitus	0.000158	0.000718	CcSEcCtD
Ezogabine—Asthenia—Losartan—type 2 diabetes mellitus	0.000156	0.00071	CcSEcCtD
Ezogabine—Rash—Metformin—type 2 diabetes mellitus	0.000155	0.000703	CcSEcCtD
Ezogabine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000154	0.000702	CcSEcCtD
Ezogabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000154	0.0007	CcSEcCtD
Ezogabine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000153	0.000696	CcSEcCtD
Ezogabine—Rash—Irbesartan—type 2 diabetes mellitus	0.000146	0.000663	CcSEcCtD
Ezogabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000146	0.000663	CcSEcCtD
Ezogabine—Nausea—Metformin—type 2 diabetes mellitus	0.000146	0.000662	CcSEcCtD
Ezogabine—Dizziness—Losartan—type 2 diabetes mellitus	0.000144	0.000655	CcSEcCtD
Ezogabine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000137	0.000625	CcSEcCtD
Ezogabine—Rash—Losartan—type 2 diabetes mellitus	0.000137	0.000624	CcSEcCtD
Ezogabine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000137	0.000624	CcSEcCtD
Ezogabine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000134	0.000609	CcSEcCtD
Ezogabine—Nausea—Losartan—type 2 diabetes mellitus	0.000129	0.000588	CcSEcCtD
Ezogabine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000123	0.000561	CcSEcCtD
Ezogabine—Rash—Ramipril—type 2 diabetes mellitus	0.000118	0.000535	CcSEcCtD
Ezogabine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000118	0.000535	CcSEcCtD
Ezogabine—Nausea—Ramipril—type 2 diabetes mellitus	0.000111	0.000504	CcSEcCtD
Ezogabine—CYP2A6—NRF2 pathway—TGFB1—type 2 diabetes mellitus	2.35e-05	0.000139	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.35e-05	0.000139	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SNAP25—type 2 diabetes mellitus	2.34e-05	0.000139	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PSMD6—type 2 diabetes mellitus	2.34e-05	0.000139	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SREBF1—type 2 diabetes mellitus	2.34e-05	0.000139	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—type 2 diabetes mellitus	2.34e-05	0.000139	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—type 2 diabetes mellitus	2.34e-05	0.000139	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-05	0.000137	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD17B3—type 2 diabetes mellitus	2.31e-05	0.000137	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACACA—type 2 diabetes mellitus	2.31e-05	0.000137	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—STAR—type 2 diabetes mellitus	2.31e-05	0.000137	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CTGF—type 2 diabetes mellitus	2.3e-05	0.000136	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMGCR—type 2 diabetes mellitus	2.28e-05	0.000135	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LPA—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—KCNJ11—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GCKR—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LPA—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSD3B2—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GCKR—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—INS—type 2 diabetes mellitus	2.26e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADRA2A—type 2 diabetes mellitus	2.23e-05	0.000132	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCC8—type 2 diabetes mellitus	2.21e-05	0.000131	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CBS—type 2 diabetes mellitus	2.21e-05	0.000131	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.18e-05	0.000129	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDOB—type 2 diabetes mellitus	2.18e-05	0.000129	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDOB—type 2 diabetes mellitus	2.18e-05	0.000129	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—type 2 diabetes mellitus	2.16e-05	0.000128	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—type 2 diabetes mellitus	2.16e-05	0.000128	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2E1—type 2 diabetes mellitus	2.14e-05	0.000127	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—COX2—type 2 diabetes mellitus	2.13e-05	0.000126	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC5A2—type 2 diabetes mellitus	2.13e-05	0.000126	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1A2—type 2 diabetes mellitus	2.12e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A1—type 2 diabetes mellitus	2.12e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.11e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GNB3—type 2 diabetes mellitus	2.1e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.1e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.09e-05	0.000124	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOA6—type 2 diabetes mellitus	2.09e-05	0.000124	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—type 2 diabetes mellitus	2.08e-05	0.000123	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.07e-05	0.000123	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAT—type 2 diabetes mellitus	2.07e-05	0.000122	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP3A4—type 2 diabetes mellitus	2.06e-05	0.000122	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UCP2—type 2 diabetes mellitus	2.06e-05	0.000122	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD11B1—type 2 diabetes mellitus	2.06e-05	0.000122	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UCP3—type 2 diabetes mellitus	2.06e-05	0.000122	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.05e-05	0.000121	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GCG—type 2 diabetes mellitus	2.03e-05	0.00012	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A4—type 2 diabetes mellitus	2.03e-05	0.00012	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GLP1R—type 2 diabetes mellitus	2.02e-05	0.00012	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GLP1R—type 2 diabetes mellitus	2.02e-05	0.00012	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOB—type 2 diabetes mellitus	2.01e-05	0.000119	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.98e-05	0.000118	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NOS3—type 2 diabetes mellitus	1.98e-05	0.000118	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.95e-05	0.000116	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PCK1—type 2 diabetes mellitus	1.93e-05	0.000115	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LPL—type 2 diabetes mellitus	1.92e-05	0.000113	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.89e-05	0.000112	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.89e-05	0.000112	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.87e-05	0.000111	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPX1—type 2 diabetes mellitus	1.87e-05	0.000111	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CPT1A—type 2 diabetes mellitus	1.85e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTR—type 2 diabetes mellitus	1.85e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CPT1A—type 2 diabetes mellitus	1.85e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTR—type 2 diabetes mellitus	1.85e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CD36—type 2 diabetes mellitus	1.82e-05	0.000108	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NAMPT—type 2 diabetes mellitus	1.81e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NAMPT—type 2 diabetes mellitus	1.81e-05	0.000107	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HK1—type 2 diabetes mellitus	1.81e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LIPC—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HBA1—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HBA1—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LIPC—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GCK—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GCK—type 2 diabetes mellitus	1.8e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.8e-05	0.000106	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.79e-05	0.000106	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.79e-05	0.000106	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.76e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.76e-05	0.000104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.75e-05	0.000104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LPA—type 2 diabetes mellitus	1.75e-05	0.000104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.75e-05	0.000104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GCKR—type 2 diabetes mellitus	1.75e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNB3—type 2 diabetes mellitus	1.75e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.75e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMOX1—type 2 diabetes mellitus	1.74e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CETP—type 2 diabetes mellitus	1.74e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CETP—type 2 diabetes mellitus	1.74e-05	0.000103	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.72e-05	0.000102	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAT—type 2 diabetes mellitus	1.72e-05	0.000102	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARA—type 2 diabetes mellitus	1.69e-05	0.0001	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDOB—type 2 diabetes mellitus	1.68e-05	9.94e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOB—type 2 diabetes mellitus	1.67e-05	9.88e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AGT—type 2 diabetes mellitus	1.64e-05	9.71e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—type 2 diabetes mellitus	1.62e-05	9.61e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.62e-05	9.61e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SNAP25—type 2 diabetes mellitus	1.62e-05	9.58e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SREBF1—type 2 diabetes mellitus	1.62e-05	9.58e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.62e-05	9.58e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PSMD6—type 2 diabetes mellitus	1.62e-05	9.58e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.62e-05	9.58e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.62e-05	9.58e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CALM1—type 2 diabetes mellitus	1.61e-05	9.55e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOE—type 2 diabetes mellitus	1.61e-05	9.51e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LPL—type 2 diabetes mellitus	1.59e-05	9.43e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CTGF—type 2 diabetes mellitus	1.59e-05	9.4e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-05	9.4e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CTGF—type 2 diabetes mellitus	1.59e-05	9.4e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.57e-05	9.32e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMGCR—type 2 diabetes mellitus	1.57e-05	9.32e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GLP1R—type 2 diabetes mellitus	1.56e-05	9.24e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADCY5—type 2 diabetes mellitus	1.56e-05	9.24e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPX1—type 2 diabetes mellitus	1.55e-05	9.2e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.55e-05	9.19e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.54e-05	9.12e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.54e-05	9.12e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CD36—type 2 diabetes mellitus	1.51e-05	8.96e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.49e-05	8.85e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.48e-05	8.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.48e-05	8.76e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.46e-05	8.66e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.46e-05	8.66e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.46e-05	8.66e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.46e-05	8.66e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.46e-05	8.62e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—type 2 diabetes mellitus	1.43e-05	8.49e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CPT1A—type 2 diabetes mellitus	1.43e-05	8.45e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTR—type 2 diabetes mellitus	1.43e-05	8.45e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.43e-05	8.45e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.43e-05	8.45e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.42e-05	8.41e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARA—type 2 diabetes mellitus	1.41e-05	8.33e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GCG—type 2 diabetes mellitus	1.4e-05	8.31e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GCG—type 2 diabetes mellitus	1.4e-05	8.31e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.4e-05	8.31e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.4e-05	8.31e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-05	8.29e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NAMPT—type 2 diabetes mellitus	1.4e-05	8.29e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HBA1—type 2 diabetes mellitus	1.39e-05	8.23e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GCK—type 2 diabetes mellitus	1.39e-05	8.23e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LIPC—type 2 diabetes mellitus	1.39e-05	8.23e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.38e-05	8.18e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—INS—type 2 diabetes mellitus	1.37e-05	8.13e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AGT—type 2 diabetes mellitus	1.36e-05	8.07e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.36e-05	8.04e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CETP—type 2 diabetes mellitus	1.34e-05	7.94e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CALM1—type 2 diabetes mellitus	1.34e-05	7.94e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOE—type 2 diabetes mellitus	1.33e-05	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOA1—type 2 diabetes mellitus	1.32e-05	7.82e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—type 2 diabetes mellitus	1.26e-05	7.45e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PSMD6—type 2 diabetes mellitus	1.25e-05	7.39e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SNAP25—type 2 diabetes mellitus	1.25e-05	7.39e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SREBF1—type 2 diabetes mellitus	1.25e-05	7.39e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CTGF—type 2 diabetes mellitus	1.22e-05	7.25e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMGCR—type 2 diabetes mellitus	1.21e-05	7.18e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNB3—type 2 diabetes mellitus	1.21e-05	7.16e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.21e-05	7.16e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.21e-05	7.16e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNB3—type 2 diabetes mellitus	1.21e-05	7.16e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-05	7.13e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-05	7.13e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.2e-05	7.13e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMOX1—type 2 diabetes mellitus	1.2e-05	7.13e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAT—type 2 diabetes mellitus	1.19e-05	7.03e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAT—type 2 diabetes mellitus	1.19e-05	7.03e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.19e-05	7.03e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—type 2 diabetes mellitus	1.16e-05	6.89e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOB—type 2 diabetes mellitus	1.15e-05	6.83e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOB—type 2 diabetes mellitus	1.15e-05	6.83e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—INS—type 2 diabetes mellitus	1.14e-05	6.76e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.14e-05	6.75e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.13e-05	6.68e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.13e-05	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—type 2 diabetes mellitus	1.12e-05	6.64e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.12e-05	6.64e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-05	6.52e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LPL—type 2 diabetes mellitus	1.1e-05	6.52e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LPL—type 2 diabetes mellitus	1.1e-05	6.52e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.1e-05	6.51e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.08e-05	6.4e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	1.08e-05	6.4e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-05	6.38e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-05	6.38e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPX1—type 2 diabetes mellitus	1.07e-05	6.36e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPX1—type 2 diabetes mellitus	1.07e-05	6.36e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CD36—type 2 diabetes mellitus	1.05e-05	6.19e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—type 2 diabetes mellitus	1.05e-05	6.19e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CD36—type 2 diabetes mellitus	1.05e-05	6.19e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.03e-05	6.12e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.03e-05	6.12e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NOS3—type 2 diabetes mellitus	1e-05	5.92e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3R1—type 2 diabetes mellitus	1e-05	5.92e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—type 2 diabetes mellitus	9.9e-06	5.87e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—type 2 diabetes mellitus	9.9e-06	5.87e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARA—type 2 diabetes mellitus	9.72e-06	5.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARA—type 2 diabetes mellitus	9.72e-06	5.76e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AGT—type 2 diabetes mellitus	9.41e-06	5.58e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AGT—type 2 diabetes mellitus	9.41e-06	5.58e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	9.31e-06	5.52e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.31e-06	5.52e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	9.27e-06	5.49e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CALM1—type 2 diabetes mellitus	9.25e-06	5.48e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CALM1—type 2 diabetes mellitus	9.25e-06	5.48e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOE—type 2 diabetes mellitus	9.22e-06	5.46e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOE—type 2 diabetes mellitus	9.22e-06	5.46e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	9.15e-06	5.42e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—type 2 diabetes mellitus	9.14e-06	5.42e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—type 2 diabetes mellitus	9.12e-06	5.41e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA1—type 2 diabetes mellitus	9.11e-06	5.4e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA1—type 2 diabetes mellitus	9.11e-06	5.4e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	8.88e-06	5.26e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	8.64e-06	5.12e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	8.48e-06	5.02e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	8.3e-06	4.92e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	8.27e-06	4.9e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	8.06e-06	4.77e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—type 2 diabetes mellitus	8.03e-06	4.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	8.03e-06	4.76e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.96e-06	4.71e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	7.88e-06	4.67e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	7.88e-06	4.67e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	7.63e-06	4.52e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	7.49e-06	4.44e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	7.25e-06	4.3e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	7.22e-06	4.28e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	7.22e-06	4.28e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	7.13e-06	4.23e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	7.11e-06	4.21e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	7.03e-06	4.16e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.91e-06	4.09e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	6.91e-06	4.09e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	6.91e-06	4.09e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.91e-06	4.09e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	6.32e-06	3.74e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	6.32e-06	3.74e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	6.19e-06	3.67e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	6.07e-06	3.6e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	5.57e-06	3.3e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—type 2 diabetes mellitus	5.53e-06	3.28e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	5.32e-06	3.16e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.32e-06	3.16e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	4.87e-06	2.89e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	4.6e-06	2.72e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-06	1.88e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-06	1.88e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	2.45e-06	1.45e-05	CbGpPWpGaD
